Investing Profile

Firas Rahhal

VC
New York, New York
Photo of Firas Rahhal, Partner at ExSight Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
140 CONNECTIONS
University of California, San Diego Network
21 CONNECTIONS
cb
2
CompanyStageDateRound SizeTotal Raised
Re-Vana Therapeutics
Series ANov 2022$12M
SeedJun 2020$3M
$15M
Co-investors: Michael Nissen (ExSight Capital Management), James C. Murray (ExSight Capital Management)
Partner ExSight Ventures2014 - Present
Partner Retina-Vitreous Associates Medical Group2004 - Present
Associate Clinical Professor of Ophthalmology David Geffen School of Medicine at UCLA - Stein Eye Institute2002 - Present
Assistant Professor of Ophthalmology / Retina Clinic Director Joan & Sanford I. Weill Medical College of Cornell University1996 - 2001
University of California, San Diego Fellowship Vitreoretinal Diseases & Surgery / Uveitis
Joan & Sanford I. Weill Medical College of Cornell University Residency in Ophthalmology
David Geffen School of Medicine at UCLA Internship Internal Medicine
University of Connecticut School of Medicine Doctor of Medicine (M.D.)
University of Pennsylvania Bachelor of Arts (B.A.) Biochemistry